Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer
Yohei Ando, Mohamad Dbouk, Takeichi Yoshida, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 18, pp. 2196-2206
Open Access | Times Cited: 11

Showing 11 citing articles:

Liquid biopsy in cancer current: status, challenges and future prospects
Liwei Ma, Huiling Guo, Yunxiang Zhao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Artificial neural network detection of pancreatic cancer from proton (1H) magnetic resonance spectroscopy patterns of plasma metabolites
Meiyappan Solaiyappan, Santosh Kumar Bharti, Raj Kumar Sharma, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
The role of biomarkers in the early detection of pancreatic cancer
Michael Goggins
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 309-322
Open Access | Times Cited: 5
Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals
M. Heller, Derek A. Mann, Bryson W. Katona
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Metabolic response during preoperative chemotherapy can predict prognosis in pancreatic cancer
Won‐Gun Yun, Tae Young Kim, Seulah Park, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2025)
Closed Access
From discovery to clinical implementation of a pancreatic blood biomarker, apolipoprotein A2 isoform
Ayumi Kashiro, Giman Jung, Kazufumi Honda
Cancer Biomarkers (2025) Vol. 42, Iss. 3
Closed Access
CD44 Identified as a Diagnostic Biomarker for Highly Malignant CA19-9 Negative Pancreatic Cancer
Jiatong Tang, Xiaoyang Li, Neng Tang, et al.
Cancer Letters (2025), pp. 217713-217713
Closed Access
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies
Lynette M. Smith, Douglas W. Mahoney, William R. Bamlet, et al.
Pancreatology (2024)
Open Access | Times Cited: 2
Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy
Yue Ma, Shiyun Chen, Guanghai Dai
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: analysis of the National Cancer Database
Toshitaka Sugawara, Salvador Rodriguez Franco, Samantha N. Sherman, et al.
Pancreatology (2024) Vol. 24, Iss. 8, pp. 1340-1347
Closed Access
DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis
Xiaowen Gong, Yue Xuan, Calver Pang, et al.
Clinica Chimica Acta (2024) Vol. 567, pp. 120080-120080
Closed Access
Page 1

Scroll to top